IN2014DN08266A - - Google Patents

Download PDF

Info

Publication number
IN2014DN08266A
IN2014DN08266A IN8266DEN2014A IN2014DN08266A IN 2014DN08266 A IN2014DN08266 A IN 2014DN08266A IN 8266DEN2014 A IN8266DEN2014 A IN 8266DEN2014A IN 2014DN08266 A IN2014DN08266 A IN 2014DN08266A
Authority
IN
India
Prior art keywords
treating
disease
receptor antagonist
viral
virus
Prior art date
Application number
Other languages
English (en)
Inventor
Altmeyer Ralf
Peijun Ren
Original Assignee
Inst Pasteur Shanghai Cas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Pasteur Shanghai Cas filed Critical Inst Pasteur Shanghai Cas
Publication of IN2014DN08266A publication Critical patent/IN2014DN08266A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN8266DEN2014 2012-03-09 2013-03-11 IN2014DN08266A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201210062620 2012-03-09
PCT/CN2013/072402 WO2013131496A1 (zh) 2012-03-09 2013-03-11 治疗病毒疾病的成分和方法

Publications (1)

Publication Number Publication Date
IN2014DN08266A true IN2014DN08266A (zh) 2015-05-15

Family

ID=49115954

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8266DEN2014 IN2014DN08266A (zh) 2012-03-09 2013-03-11

Country Status (9)

Country Link
US (1) US9872875B2 (zh)
EP (1) EP2875829A4 (zh)
JP (1) JP6116596B2 (zh)
KR (1) KR20150005526A (zh)
CN (1) CN103301462B (zh)
IN (1) IN2014DN08266A (zh)
MY (1) MY169687A (zh)
SG (1) SG11201405559TA (zh)
WO (1) WO2013131496A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108014341A (zh) * 2017-12-28 2018-05-11 南京东诺医药科技开发有限责任公司 抗炎组合物及其应用
CN110064044B (zh) * 2018-01-20 2022-09-09 中国科学院武汉病毒研究所 一种肠道病毒71型的抑制剂及应用
CN108685888A (zh) * 2018-05-24 2018-10-23 南方医科大学 Nf023在制备多效杀微生物剂及hiv性传播阻断剂中的应用
CN108553472A (zh) * 2018-05-24 2018-09-21 南方医科大学 Nf546在制备多效杀微生物剂及hiv性传播阻断剂中的应用
CN115211402A (zh) * 2022-07-07 2022-10-21 中国医学科学院医学生物学研究所 一种cv-b3感染的啮齿动物模型的构建方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6280928B1 (en) * 1998-04-24 2001-08-28 Diagnostic Hybrids, Inc. Mixed cell diagnostic systems
ES2223287B1 (es) * 2003-08-04 2006-04-16 Universidad Del Pais Vasco-Euskal Herriko Unibertsitatea Compuestos para el tratamiento de enfermedades desmielinizantes y autoinmunes.
HUP0500145A2 (en) * 2005-01-28 2006-11-28 Gene Res Lab N Use of o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime for preparation of medicaments against oral diseases
BRPI0822058A2 (pt) 2007-12-18 2015-06-23 Glaxo Group Ltd Derivados de 5-oxo-3-pirrolidinacarboxamida como moduladores de p2x7
CN101780278B (zh) * 2009-09-29 2012-02-01 福尔生物制药股份有限公司 二联手足口病灭活疫苗
CN101695569A (zh) * 2009-11-03 2010-04-21 中国人民解放军军事医学科学院微生物流行病研究所 一种手足口病单、双价基因工程亚单位疫苗及其制备方法
US8710079B2 (en) 2010-04-23 2014-04-29 National Health Research Institutes Quinoline compounds and their use for treating viral infection
US9051361B2 (en) * 2010-08-17 2015-06-09 National Health Research Institutes Immunogenic compositions and uses thereof
CN102178678B (zh) * 2011-03-18 2012-12-19 中国医学科学院医学实验动物研究所 石蒜碱在制备治疗人肠道病毒71型感染引发疾病的药物的应用

Also Published As

Publication number Publication date
CN103301462A (zh) 2013-09-18
SG11201405559TA (en) 2014-11-27
US20150045318A1 (en) 2015-02-12
EP2875829A1 (en) 2015-05-27
EP2875829A4 (en) 2015-12-02
MY169687A (en) 2019-05-13
WO2013131496A1 (zh) 2013-09-12
JP2015510870A (ja) 2015-04-13
JP6116596B2 (ja) 2017-04-19
US9872875B2 (en) 2018-01-23
CN103301462B (zh) 2015-06-03
KR20150005526A (ko) 2015-01-14

Similar Documents

Publication Publication Date Title
MY186752A (en) Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection
TN2013000485A1 (en) 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
MX358099B (es) Anticuerpos que neutralizan el virus de inmunodeficiencia humano y metodos de uso de ellos.
HK1203944A1 (zh) 用於治療和預防乙型肝炎病毒感染的 -甲基-二氫嘧啶類
TN2015000185A1 (en) 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
IN2014DN09173A (zh)
MX2012009581A (es) Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza.
MD4602B1 (ro) Inhibitori ai virusului hepatic C
EA026667B9 (ru) Фармацевтическая композиция для лечения вируса гепатита с
MY197723A (en) Vaccine compositions for the prevention of dengue virus infection
PH12014502875A1 (en) Vaccine compositions for prevention against dengue virus infection
PH12015502230B1 (en) Novel viral replication inhibitors
HRP20190393T1 (hr) Pripravak protutijela namijenjen sprječavanju ili liječenju infekcije mutantnim virusom hepatitisa b
PH12016501968A1 (en) Novel macrocyclic compounds
IN2014DN08266A (zh)
MX2013012233A (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas sustituidas.
JO3281B1 (ar) مركبات بينزوفوران لمعالجة عدوى فيروس إلتهاب الكبد الوبائي
EP2893936A4 (en) METHOD AND AGENT FOR THE TREATMENT AND PROPHYLAXIS OF DISEASES MEDIATED BY (+) RNA-CONTAINING VIRUSES
MY171497A (en) Crystalline forms of dihydropyrimidine derivatives
PH12016502322A1 (en) Compounds and methods for preventing or treating malaria
ZA201307019B (en) Compositions for preventing and/or treating and infection by an hiv-1 virus
IN2011CH03893A (zh)
EA019080B9 (ru) α-КРИСТАЛЛИЧЕСКАЯ ФОРМА КАРБАБЕНЗПИРИДА
IN2014DN10683A (zh)
ZA201407866B (en) Composition for the prevention and treatment of viral infections caused by retroviruses